SmeOP-TolCsm Efflux Pump Contributes to the Multidrug Resistance of Stenotrophomonas maltophilia
Cheng-Wen Lin
1, Yi-Wei Huang
2, Rouh-Mei Hu
3,4, and Tsuey-Ching Yang
2*1
Department of Medical Laboratory Science and Biotechnology, China Medical
University, Taichung 404, Taiwan
2
Department of Biotechnology and Laboratory Science in Medicine, National Yang-
Ming University, Taipei, 112, Taiwan
3
Department of Biotechnology, Asia University, Taichung, 413, Taiwan
4
Department of Biomedical Informatics, Asia University, Taichung, 413, Taiwan
Running title: SmeOP-TolCsm of S. maltophilia
For correspondence.
E-mail: tcyang@ ym .edu.tw
Mailing address: 155 Section 2, Lie-Nong Street, Taipei, 112, Taiwan, R.O.C.
Tel: 886-2-28267289 Fax: 886-2-28264092 Abstract
A five-gene cluster, tolCsm-pcm-smeRo-smeO-smeP, of Stenotrophomonas 1
2 3
4 5 6
7 8
9
10
11
12
13
14
15
16
17
18
19
20
21
maltophilia was characterized. The presence of smeOP and smeRo-pcm-tolCsm
operons was verified by RT-PCR. Both operons were negatively regulated by the TetR-type transcriptional regulator SmeRo, as demonstrated by quantitative-RT-PCR and promoter-fusion assay. SmeO and SmeP were associated with TolCsm for assembly of a RND-type pump. The compounds extruded by SmeOP-TolCsm mainly included nalidixic acid, doxycycline, amikacin, gentamicin, erythromycin, leucomycin, carbonyl cyanide 3-chlorophenylhydrazone, crystal violet, sodium dodecyl sulfate, and tetrachlorosalicylanilide.
Keywords: bacteria, antibiotics resistance, efflux pump
Multidrug efflux transporters capable of active extrusion of noxious compounds are classified into five families, including Resistance Nodulation cell Division (RND) family, Major Facilitator Superfamily (MFS), Small Multidrug Resistance (SMR) 22
23 24 25 26 27 28
29
30
31
32
33
34
35
36
37
38
39
40
41
family, ATP Binding Cassette (ABC) family, and Multidrug and Toxic compound Extrusion (MATE) family (1). The RND systems generally form tripartite components composed of a periplasmic membrane fusion protein (MFP), an inner
membrane RND transporter, and an outer membrane protein (OMP) (2).
Stenotrophomonas maltophilia is a non fermentative Gram-negative bacillus.
Eight RND-type efflux systems, SmeABC, SmeDEF, SmeGH, SmeIJK, SmeMN, SmeOP, SmeVWX, and SmeYZ, are postulated in the S. maltophilia genome (3).
Among them, the SmeABC, SmeDEF, SmeIJK, SmeVWX, and SmeYZ have been characterized (4-7). A possible promiscuous OMP TolCsm involved in the multidrug resistance has been proposed (8). Referring from the genome sequence of S.
maltophilia, we noted that the tolCsm gene and the smeOP system are located nearby
(Fig. 1), implying that smeOP and tolCsm may be involved in a common mechanism for the antibiotics extrusion. SmeO and smeP were predicted to encode a MFP and a RND-type inner membrane transporter. A TetR-type transcription regulator (annotated as SmeRo hereafter) was located immediately upstream of the smeOP and divergently transcribed. The genes downstream of the smeRo were the pcm-tolCsm operon, which has been known to contribute to multidrug resistance (8).
SmeRo acts as a regulator for the expression of smeOP
To evaluate the regulatory role of smeRo, a smeRo deletion mutant, KJRo, was 42
43 44
45 46 47 48 49 50 51 52 53 54 55 56 57
58
59
60
61
constructed. A 359-bp DNA fragment (27-bp N-terminus of pcm, intergenic region of pcm and smeRo, and 198-bp C-terminus of smeRo) and a 434-bp DNA fragment (276-
bp N-terminus of smeRo, intergenic region of smeRo and smeO, and 33-bp N terminus of smeO) were amplified with primers SmeRo3-F/SmeRo3-R and SmeRo5- F/SmeRo5-R (Fig. 1, Table S1), respectively, and sequentially cloned into pEX18Tc, yielding plasmid pRo for the construction of KJRo. The resultant in-frame deletion mutant, KJRo, was with an internal deletion in the smeRo gene from nt 273 to nt 494. The transcripts of smeO, smeP, pcm, and tolCsm in KJ and KJRo were determined by qRT-PCR. The qRT-PCR was carried out at least in triplicate (6) and the primers used are listed in Table S1. The transcripts of smeO, smeP, pcm, and tolCsm in KJRo were greater than those in KJ by a factor of 4.6 2.1, 3.8 1.9, 1.5
0.6, and 1.4 0.5, respectively. The effect of smeRo deletion on the expression of pcm and tolCsm was notably minor. Therefore, SmeRo played a regulatory role, presumably a repressor, in the expression of smeOP.
SmeRo, pcm, and tolCsm form an operon
Based on the genetic organization, we considered the possible presence of the smeRo- pcm-tolCsm operon. To test it, an RT-PCR analysis was performed on the mRNA extracted from KJ and KJRo. Primer TolCQ-R (Table S1, Fig. 1B) was used for the 62
63 64 65 66 67 68 69 70 71 72 73 74
75
76
77
78
79
80
obtainment of cDNA. A 670-bp amplicon I (primered by 23-F/23-R) and an 1123-bp amplicon II (primered by 123-F/23-R) were detected in KJRo, but only the amplicon I was observed in KJ (Fig. 1B). KJRo is an in-frame deletion mutant with an internal deletion in smeRo gene from nt 273 to nt 494. The primers of 123-F and 23-R targeted onto the 221-241 nts of the smeRo gene and the 48-65 nts of the tolCsm gene (Fig.
1B). Therefore, an 1123-bp amplicon II can be amplified only if smeRo-pcm-tolCsm are co-transcribed. A smeRo-pcm-tolCsm transcript was observed in KJRo, but not in KJ even though the number of PCR cycles was increased to 40 (Fig. 1B). These observations support that a smeRo-pcm-tolCsm transcript was slightly expressed in KJRo and a pcm-tolCsm transcript was expressed in KJ and KJRo.
Assays of promoter activities of smeRo-pcm-tolCsm and smeOP operons
To further study the regulatory circuits, transcriptional xylE fusions to promoters of the smeOP operon (pSmeO
xylE), smeRo-pcm-tolCsm operon (pSmeRo
xylE), pcm- tolCsm operon (pPCM
xylE), and tolCsm (pTolC
xylE) were constructed (Fig. 1A) and introduced into KJ and KJRo, respectively. The expressed C23O activities were monitored, as described previously (9). KJRo(pSmeO
xylE) exhibited a higher C23O activity than KJ(pSmeO
xylE) (Table 1), further confirming that SmeRo plays a repressor role in the expression of smeOP operon. Compared to KJ(pSmeRo
xylE), 81
82 83 84 85 86 87 88 89
90
91
92
93
94
95
96
97
98
99
KJRo(pSmeRo
xylE) had a slightly higher C23O activity (Table 1), which signifies the slightly negative autoregulation of smeRo. KJ(pPCM
xylE) and KJRo(pPCM
xylE) exhibited comparable C23O activities, indicating that the promoter of the pcm-tolCsm operon is constitutively active and not subjected to the regulation of SmeRo. No significant C23O activity was observed in KJ(pTolC
xylE) and KJRo(pTolC
xylE), supporting that there is no promoter activity in the 243-bp upstream region of the tolCsm gene.
Substrate spectrum of the SmeOP efflux pump
A 1405-bp DNA fragment containing partial C-terminus of smeP, amplified with primers SmeP3-F and SmeP3-R, and the aforementioned 434-bp DNA fragment (primered by SmeRo5-F/SmeRo5-R) were sequentially cloned into pEX18Tc, yielding plasmid pOP (Fig. 1A, Table S1). The SmeOP in-frame deletion mutant, KJOP, was obtained using the same strategy described in Ref. 6. The 1103-bp C- terminus of smeO gene and 2802-bp N-terminus of smeP gene in mutant KJOP were deleted (Fig. 1A). The substrate spectrum of SmeOP was assessed by comparing the antimicrobials susceptibilities between KJ and KJOP as well as KJRo and KJRoOP (Table 2). Susceptibility assay was tested by the agar dilution method, as described previously (6), at least three replicates. The results concluded that SmeOP 100
101 102 103 104 105
106
107
108
109
110
111
112
113
114
115
116
117
118
was responsible for the extrusion of nalidixic acid, doxycycline, aminoglycosides, macrolides, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), crystal violet, sodium dodecyl sulfate (SDS), and tetracholorsalicylanilide (TCS). Among them, aminoglycosides, CCCP, and TCS were the most significant ones
Complementation test for smeRo mutant
To confirm whether the phenotype observed in KJRo was due to inactivation of the smeRo gene, plasmid pSmeRo (containing the full-length smeRo) was introduced into
the KJRo, yielding KJRo(pSmeRo). The transcripts of smeO, smeP, pcm, and tolCsm in KJRo(pSmeRo) were lower than those in KJRo(pRK415) by a factor of
2.6 1.1, 2.3 1.0, 1.1 0.4, and 1.1 0.5, respectively. The susceptibility of KJ(pRK415), KJRo(pRK415), and KJRo(pSmeRo) to aminoglycoside, CCCP, and TCS was tested by the agar dilution method and the disk diffusion assay. The complementation of KJRo with pSmeRo increased the resistance to aminoglycoside, CCCP, and TCS (Table S2).
SmeOP requires TolCsm for efflux pump function
Inactivation of the smeOP operon decreased the MICs to some antibiotics (Table 2), indicating that the smeOP and its cognate OMP gene should be expressed constitutively in the wild-type KJ. Four possible OMP candidates, SmeC, SmeF, 119
120 121
122 123 124 125 126 127 128 129 130 131 132
133
134
135
136
137
138
SmeX, and TolCsm for the RND-type efflux pumps, have been proposed (8). Of the four OMPs, the transcripts of smeF and tolCsm were observed and no significant transcripts of smeC and smeX were detected by the assessment of RT-PCR (Fig. S1).
Therefore, SmeC and SmeX were less likely to be the cognate OMP of the SmeOP efflux pump. To assess the possibility of SmeOP-SmeF, the smeDEF operon was deleted from the chromosomes of strains KJ and KJOP, generating mutants KJDEF and KJDEFOP, respectively. Compared to KJDEF, KJDEFOP obviously compromised its resistance to aminoglycoside and leucomycin (Table 2), indicating that the SmeOP pump is still functional in the case of smeF inactivation. The possibility of SmeOP-TolCsm was also evaluated. The susceptibility of KJTolC reported in our previous study (8) was also included in Table 3 for comparison. The introduction of smeOP into KJTolC did not further compromise the resistance of KJTolC to all compounds tested (Table 2, KJTolC vs. KJTolCOP), supporting that TolCsm is the cognate OMP for the SmeOP pump. Moreover, deletion of the tolCsm gene was associated with a greater decrease in MICs than those caused by
deletion of smeOP (Table 2), signifying the promiscuous role of TolCsm. TolCsm may not only participate in the function of the SmeOP pump, but also in the function
of other hitherto uncharacterized efflux systems.
Distinct from the tolC orthologs reported in Enterobacteriaceae 139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
and P. aeruginosa, tolCsm of S. maltophilia locates in a pcm-tolCsm operon. The protein-L-isoaspartate O-methyltransferase (PCM) encoded by pcm is an enzyme that recognizes and catalyzes the repair of damaged L-isoaspartyl and D-aspartatyl groups in proteins.
PCM may thus involve in the repair of damaged TolCsm and keep TolCsm in a functional state. Recently, we have verified that the pcm gene is less related to the TolCsm function in the aspect of antimicrobial extrusion (8). However, in addition to antimicrobial efflux function, TolC-associated pumps are also known to play physiological roles for stresses adaption, such as envelope stress or oxidative stress (10). Therefore, it can not be immediately ruled out that PCM play an important role in the physiological function of TolCsm.
Acknowledgement
This research was supported by the National Science Council (NSC 101-2320-B-010- 053-MY3).
158 159 160 161 162 163 164 165 166 167 168 169
170
171
172
173
174
175
176
177
References
1. Putman M, van Veen HW, Konings WN. 2000. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol.
Rev. 64:672-693.
2. Femandez-Recio J, Walas F, Federici L, Venkatesh Pratap J, Bavro VN, Miguel RN, Mizuguchi K, Luisi B. 2004. A model of a transmembrane drug- 178
179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195
196
197
198
efflux pump from Gram-negative bacteria. FEBS Lett. 578:5-9.
3. Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, Adlem E, Kerhornou A, Lord A, Murphy L, Seeger K, Squares R, Rutter S, Quail MA, Rajandream MA, Harris D, Churcher C, Bentley SD, Parkhill J, Thomson NR, Avison MB.
2008. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug
resistance determinants. Gen. Biol. 9:R74.
4. Li, XZ, Li Z, Poole K. 2002. SmeC, an outer membrane multidrug efflux protein
of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 46:333-343.
5. Alonso A, Martinez JL. 2000. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob. Agents
Chemother. 44:3079–3086.
6. Chen CH, Huang CC, Chung TC, Hu RM, Huang YW, Yang TC. 2011.
Contribution of resistance-nodulation-division efflux pump operon smeU1-V-W- U2-X to multidrug resistance of Stenotrophomonas maltophilia. Antimicro. Agents Chemother. 55:5826-5833.
199 200 201 202 203 204 205
206 207
208 209 210
211
212
213
214
215
7. Gould VC, Okazaki A, Avison MB. 2013. Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia.
Antimicrob. Agents Chemother. 57:655-657.
8. Huang YW, Hu RM, Yang TC. 2013. Role of the pcm-tolCsm operon in multidrug resistance of Stenotrophomonas maltophilia. J. Antimicrob. Chemother.
68:1987-1993.
9. Huang YW, Lin CW, Hu RM, Lin YT, Chung TC, Yang TC. 2010. AmpN- AmpG operon is essential for expression of L1 and 2 -lactamases in Stenotrophomonas maltophilia. Antimicro. Agents Chemother. 54:2583-2589.
10. Zgurskaya HI, Krishnamoorthy G, Ntreh A, Lu S. 2011. Mechanism and function of the outer membrane channel TolC in multidrug resistance and physiology of Enterobacteria. Front. Microbiol. 2:189.
Figure Legends
Fig. 1. Schematic organization of the smeOP and smeRo-pcm-tolCsm operons from S. maltophilia KJ. The smeOP operon contains genes for a membrane fusion protein (SmeO) and a RND transporter (SmeP). A TetR-type transcriptional regulator smeRo is located immediately upstream of the smeOP operon and is divergently transcribed. SmeRo, pcm, and tolCsm genes form an operon. Solid arrows represent ORFs and the direction of transcription. (A) The structure of recombinant plasmids.
The solid lines represent the PCR amplicons and the empty bars represent the deleted 216
217 218
219 220
221 222 223
224 225 226
227
228
229
230
231
232
233
234
235
236
237
238
region for each plasmid construct. The numbers above the solid bars represent the PCR amplicon size (bps).The arrow with dashed lines indicates the xylE gene. The black bars with vertical line indicate the product of qRT-PCR. (B) The presence of smeRo-pcm-tolCsm operon. The solid bars labeled as I and II indicate the products of RT-PCR generated by primers 23-F/23-R and 123-F/23-R, respectively. The numbers in the brackets represent the PCR amplicon sizes (bps). The fine arrows indicate the positions of primers. The empty bar represents the deleted region in strain KJRo.
The agarose gels show the RT-PCR products of strains KJ and KJRo. Lane 1, strain KJ; lane 2, strain KJRo. The RT-PCR products, labeled as I and II, were generated by primers 23-F/23-R and 123-F/23-R, respectively. The subscript numbers indicate the number of PCR cycles.
Supplemental Materials
Fig. S1
Fig. S1. Agarose gel of RT-PCR products of smeC, smeF, smeX, and tolCsm. Total cellular RNA of strain KJ was extracted from exponentially growing cells using the PureLinkTM Total RNA Purification System (Invirtogen, Carlsbad, CA, USA) and treated with 1 unit of RNase-free DNaseI (Invitrogen, Carlsbad, CA, USA). The DNase-treated RNA was converted to cDNA using the MMLV Reverse Transcriptase
1 2 3 4 239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
1
stStrand cDNA Synthesis Kit (Epicentre Biotechnologies, Taiwan). The cDNA was then used directly as a template for RT-PCR. Lane 1: transcript of partial smeC gene (primered by SmeCQ-F/SmeCQ-R); Lane 2: transcript of partial smeF gene (primered by SmeFQ-F/SmeFQ-R); Lane 3: transcript of partial smeX gene (primered by SmeXQ-F/SmeXQ-R); Lane 4: transcript of partial tolCsm gene (primered by TolCQ- F/TolCQ-R).
TABLE S1. Bacterial strains, plasmids and primers used in this study Strain,
plasmid, or primer
Genotype or properties Reference
S. maltophilia
KJ Wild type, a clinical isolate from Taiwan 1
KJOP S. maltophilia KJ double mutant of smeO and smeP genes; smeO, smeP
This study KJRo S. maltophilia KJ mutant of smeRo gene; smeRo This study KJRoOP S. maltophilia KJ mutant of smeRo, smeO, and smeP
genes; smeRo, smeO, smeP
This study KJDEF S. maltophilia KJ mutant of smeDEF operon; smeDEF This study KJDEFOP S. maltophilia KJ mutant of smeDEF and smeOP
operons; smeDEF, smeOP
This study KJTolC S. maltophilia KJ mutant of tolCsm gene; tolCsm This study KJTolCOP S. maltophilia KJ mutant of tolCsm gene and smeOP
operon; TolCsm, smeOP
This study Escherichia
coli
DH5 F- 80dlacZM15 (lacZYA-argF)U169 deoR recA1 endA1 hsdR17 (r
k-m
k+) phoA supE44
-thi-1 gyrA96
Invitrogen 266
267 268 269 270
271
272
273
274
275
276
relA1 S17-1
Plasmids
pir + mating strain 2
pEX18Tc sacB oriT, Tc
r3
pRK415 Mobilizable broad-host-range plasmid cloning vector, RK2 origin; Tc
r4 pTXylE Plasmid containing the xylE cassette; Amp
r1 pRo pEX18Tc vector with a 779-bp DNA fragment of S.
maltophilia KJ, containing the smeRo gene with a internal 235-bp deletion; Tc
rThis study
pOP pEX18Tc vector with a 1820-bp DNA fragment of S.
maltophilia KJ, containing the partial N-terminus of smeO gene and partial C-terminus of smeP gene; Tc
rThis study
pDEF pEX18Tc vector with a 752-bp DNA fragment of S.
maltophilia KJ, containing the partial N-terminus of smeD gene and partial C-terminus of smeF gene; Tc
rThis study
pTolC pEX18Tc vector with a 1563-bp DNA fragment of S.
maltophilia KJ, containing the tolC gene with a internal 100-bp deletion; Tc
r5
pSmeRo
xylEpRK415 with a 117-bp DNA fragment upstream from the smeRo start codon and a P
smeRo::xylE
transcriptional fusion
This study
pSmeO
xylEpRK415 with a 117-bp DNA fragment upstream from the smeO start codon and a P
smeO::xylE
transcriptional fusion
This study
pPCM
xylEpRK415 with a 359-bp DNA fragment upstream from the pcm start codon and a P
pcm::xylE
transcriptional fusion
This study
pTolC
xylEpRK415 with a 243-bp DNA fragment upstream from the tolCsm start codon and a P
tolCsm::xylE transcriptional fusion
This study
Primers SmeRo3-F:
SmeRo3-R SmeRo5-F SmeRo5-R
5’-CGGCCTGCAGGAAATCACCGAC-3’
5’-GCGAGCTCGGGCGTAATCAATC-3’
5’-CCCAAAGCTTACCGCCCATCCAG-3’
5’-CCACTGCAGGGCATCGGGCAG-3’
This study
This study
This study
This study
SmeP3-F SmeP3-R SmeD5-F SmeD5-R SmeF3-F SmeF3-R PCMQ-F PCMQ-R TolCQ-F TolCQ-R SmeOQ-F SmeOQ-R SmePQ-F SmePQ-R SmeCQ-F SmeCQ-R SmeFQ-F SmeFQ-R SmeXQ-F SmeXQ-R rDNA-F rDNA-R OPIG-F OPIG-R 23-F 23-R 123-F
5’-GACAAGCTTCCTGCTGCTGTTCCG-3’
5’-AGCCCGCAAGCTTGACTTAACC-3’
5’-CCAGATCTTCATCGAGCTGTCC-3’
5’-GAGGTACCATACCACGTTGTCC-3’
5’-AGACTCTAGATGTCAACGAACAGTTCAC-3’
5’-TAGCAAGCTTCGTCCAGGCTGACATTCAAC-3’
5’-CGATTGATTACGCCCACGCC-3’
5’-TCCAGCACTTCGTCACCCG-3’
5’-CCTGACCCTGAACGTGCC -3’
5’-CTCTGTGCCGAGACCACC-3’
5’-GTACTGGTGGTTCACCCC-3’
5’-GTCAGCCACGTCCAGTTC-3’
5’- GTCAGCCAGTTCCTGTCC -3’
5’- TACTCCATCGTCGCCACC -3’
5’-GCGATGCCAACAGCGAGACC-3’
5’-GTCGCCACTTCAGCCACCAG-3’
5’-CCCGAGCATCTCGCTGAC-3’
5’-AAGCCCACCTGGATCGAC-3’
5’-TACGACCGCCGCAAGCAACC-3’
5’-CAGCTCGAAGTAGTTGCGTGCC-3’
5’-GACCTTGCGCGATTGAATG-3’
5’-CGGATCGTCGCCTTGGT-3’
5’-TGAACGCGGGTGACTGGG-3’
5’-CGCACCACCATCGCCTTG-3’
5’-GGACGTGCTGGACATCAAGG-3’
5’-GCGGCATGGGCAGACAAC-3’
5’-GTTCTCCGAGGCCGTGCAGT-3’
This study This study This study This study This study This study
5 5 5 5 This study This study
6 6 6 6 6 6 6 6 6 6 This study This study This study This study This study 277
278
279
280
281
282
TABLE S2. Antimicrobial susceptibilities of strains KJ(pRK415), KJRo(pRK415), and KJRo(pSmeRo)
Strains
MIC (g ml
-1)
aDiameter of inhibition zone (mm)
bAMK GEN KAN CCCP TCS
KJ(pRK415) KJRo(pRK415) KJRo(pSmeRo)
1024
>1024 1024
512 1024
256
256 512 256
14 1 10 1 15 0.5
15 1 10 0.5
14 1 AMK, amikacin; GEN, gentamicin; KAN, kanamycin; CCCP, carbonyl cyanide 3-
chlorophenylhydrazone; TCS, tetrachlorosalicylanilide
a
The Mueller-Hinton agar contains 30 g/ml tetracycline in addition to the antibiotic
indicated.
b